Professional organizations and their role in advocacy.

Semin Oncol Nurs

Department of International Affairs, American Society of Clinical Oncology, Alexandria, VA, USA.

Published: November 2002

Objectives: To review the role of professional organizations in advocacy using the ONS as a paradigm.

Data Sources: Professional journals, organization publications, personal experiences, and internet websites.

Conclusions: Professional organizations are a crucial component of the legislative process as they seek to develop and implement sound public policy. The ONS and other organizations have realized that the work each group does individually is often more effective when the groups collaborate with others possessing the same agendas and priorities.

Implications For Nursing Practice: As the professional organization for nurses in cancer care, ONS has an active engagement in the establishment of health policy that will have an impact on nursing and cancer care. To be successful in the public policy arena, ONS must not only be aware of current issues at both the state and national levels but also must teach its members how to advocate effectively for issues that affect cancer care.

Download full-text PDF

Source
http://dx.doi.org/10.1053/sonu.2002.35936DOI Listing

Publication Analysis

Top Keywords

professional organizations
12
cancer care
12
public policy
8
professional
5
organizations role
4
role advocacy
4
advocacy objectives
4
objectives review
4
review role
4
role professional
4

Similar Publications

EBSA at 40 - an updated history.

Eur Biophys J

January 2025

Biochemistry Department, South Parks Road, Oxford, OX1 3QU, UK.

The European Biophysical Societies' Association (EBSA) is an association of 32 biophysical societies in Europe dedicated to the promotion of excellence in biophysics. Through cooperation and collaborative activities, EBSA makes a major and positive impact on the European and International biophysics community. Biennial congresses at various European locations, organized by host societies, are a major activity that engages biophysicists with the wider international scientific community.

View Article and Find Full Text PDF

Lynch Syndrome: Similarities and Differences of Recommendations in Published Guidelines.

J Gastroenterol Hepatol

January 2025

Department of Gastroenterology and Hepatology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Background: In this review, we aimed to compare the recommendations for Lynch syndrome (LS).

Methods: We compared the LS's guidelines of different medical societies, including recommendations for cancer surveillance, aspirin treatment, and universal screening.

Results: Most guidelines for LS patients recommend intervals of 1-2 years for performing colonoscopy, though there is disagreement regarding the age to begin CRC screening (dependent on status as a MLH1/MSH2 or MSH6/PMS2 carrier).

View Article and Find Full Text PDF

Aim: Several wordings of the definition of severe hypoglycaemia (SH) exist. This study aims to evaluate how different SH definition wordings affect SH history assessment.

Methods: In this cross-sectional study, surveys were emailed to registrants of the T1D Exchange, a U.

View Article and Find Full Text PDF

Objectives: Ageism occurs across the world, with negative consequences for individuals and societies. In 2016, WHO received a mandate from its Member States to lead the global campaign to combat ageism. To monitor, evaluate, and build evidence for reducing ageism, the availability of a brief, reliable and valid set of indicators of ageism experiences that can be used globally is essential.

View Article and Find Full Text PDF

How We Treat ANCA-Associated Vasculitis: A Focus on the Maintenance Therapy.

J Clin Med

January 2025

University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnet and RITA-ERN Member) with Nephrology and Dialysis Unit and Center of Immuno-Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, ASL Città di Torino and University of Torino, 10154 Turin, Italy.

Recent progress has notably improved outcomes for patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV), namely granulomatosis with polyangiitis and microscopic polyangiitis. Since 2021, several international scientific societies have recommended rituximab (RTX) as the preferred primary treatment for maintaining remission in AAV patients. Decisions regarding retreatment with RTX are based on individual patient risk factors for disease flare-ups and the potential consequences of such flares.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!